BNP Paribas Financial Markets’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-6
| Closed | -$2 | – | 3809 |
|
|
2018
Q1 | $2 | Hold |
6
| – | – | ﹤0.01% | 3627 |
|
|
2017
Q4 | $10 | Hold |
6
| – | – | ﹤0.01% | 3515 |
|
|
2017
Q3 | $9 | Hold |
6
| – | – | ﹤0.01% | 3542 |
|
|
2017
Q2 | $10 | Sell |
6
-2
| -25% | -$3 | ﹤0.01% | 3579 |
|
|
2017
Q1 | $26 | Sell |
8
-53
| -87% | -$172 | ﹤0.01% | 3444 |
|
|
2016
Q4 | $318 | Sell |
61
-269
| -82% | -$1.4K | ﹤0.01% | 3397 |
|
|
2016
Q3 | $8.31K | Buy |
330
+140
| +74% | +$3.53K | ﹤0.01% | 3261 |
|
|
2016
Q2 | $4.7K | Buy |
+190
| New | +$4.7K | ﹤0.01% | 3295 |
|
|
2016
Q1 | – | Sell |
-1,007
| Closed | -$37.4K | – | 3374 |
|
|
2015
Q4 | $37.4K | Sell |
1,007
-28
| -3% | -$1.04K | ﹤0.01% | 3003 |
|
|
2015
Q3 | $50.4K | Buy |
1,035
+662
| +177% | +$32.3K | ﹤0.01% | 2860 |
|
|
2015
Q2 | $25.7K | Buy |
+373
| New | +$25.7K | ﹤0.01% | 2888 |
|
|
2014
Q3 | – | Sell |
-28
| Closed | -$753 | – | 3805 |
|
|
2014
Q2 | $753 | Hold |
28
| – | – | ﹤0.01% | 3024 |
|
|
2014
Q1 | $628 | Hold |
28
| – | – | ﹤0.01% | 2544 |
|
|
2013
Q4 | $682 | Buy |
+28
| New | +$682 | ﹤0.01% | 3362 |
|